Valeo Financial Advisors, LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 2 filers reported holding GW PHARMACEUTICALS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Valeo Financial Advisors, LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$149,000
+81.7%
687
-3.5%
0.01%
+75.0%
Q4 2020$82,000
+10.8%
712
-6.6%
0.00%
-33.3%
Q3 2020$74,000
-32.7%
762
-15.1%
0.01%
-40.0%
Q2 2020$110,000
+52.8%
897
+17.7%
0.01%
+25.0%
Q1 2020$72,000
+50.0%
762
+64.9%
0.01%
+60.0%
Q4 2019$48,000
+60.0%
462
+76.3%
0.01%
+66.7%
Q3 2019$30,000
+172.7%
262
+322.6%
0.00%
+200.0%
Q2 2019$11,000
-75.0%
62
-76.3%
0.00%
-80.0%
Q1 2019$44,000
+69.2%
2620.0%0.01%
+25.0%
Q4 2018$26,000
-27.8%
2620.0%0.00%
-20.0%
Q3 2018$36,000
+1100.0%
262
+948.0%
0.01%
Q2 2018$3,000250.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2021
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders